Brighter's nomination committee for the Annual General Meeting 2019.
In accordance with the guidelines established at the AGM 2018, the nomination committee for Brighter's AGM 2019 has now been appointed.
The c...
Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.
In accordance with the guidelines established at the AGM 2018, the nomination committee for Brighter's AGM 2019 has now been appointed.
The c...
Brighter recruits Thor Sundsvik as Global Product Manager - Diabetes effective immediately. In this new role at Brighter, Thor will oversee and dr...
The full Interim report is available on Brighter's website https://brighter.se. The Interim report is also attached as a pdf file to this press re...
Hamza Moftah has been appointed Deputy Managing Director of Brighter's subsidiary in the United Arab Emirates, established August 2018 in collabor...
Brighter has called upon a eighth Tranche of SEK 10 million in line with the terms from the financing agreement communicated on the 26thof April 2...
The exercise period for Brighter's warrants of series TO3 is now completed. The company thereby strengthens its financing with SEK 837 628, repres...
The exercise period for Brighter's management, board and key personnel incentive programs 2014/2017 Series I & II and 2015/2018 Series I & II is n...
The mobile applications and digital infrastructure of Brighter's award-winning service for insulin treated diabetics - Actiste® Diabetes Managemen...
The exercise period for Brighter's warrants of series TO4 is now completed. The company thereby strengthens its financing with SEK 2 893 140, repr...
Brighter's CEO and COO intend to utilize their parts of the company's incentive program (2014/2017 Series II and 2015/2018 Series II). The CEO's h...
Brighter AB (publ) and AFAQ Group L.L.C. have successfully established a jointly owned corporation in Dubai, United Arab Emirates.
The new co...
The full Interim report is available on Brighter's website www.brighter.se. The Interim report is also attached as a pdf file to this press releas...
On the occasion of the Company's rights issues recalculation has been executed in accordance with the terms referring to the subscription price an...
Brighter's award-winning service for insulin-treated diabetics - Actiste® Diabetes Management as a Service - is initially introduced to the market...
The European Patent Office intend to grant Brighter's European patent application 16744322.5 regarding Artificial Intelligence-driven medical devi...
Brighter has called upon a seventh Tranche of SEK 5 million in line with the terms from the financing agreement communicated on the 26thof April 2...
Brighter AB (publ) is pleased to announce that Dr Teddy Batanghari joins as Senior Advisor. Dr. Batanghari will advise Brighter on various matters...
Brighter AB (publ) has developed estimates of segment size and ideal target markets for the company's diabetes solution Actiste® Diabetes Manageme...
At the board meeting on July 5th2018, the Board of Directors Brighter AB (publ) formally decided to initiate the process of applying for listing i...
Brighter AB (publ) and AFAQ Group L.L.C. have entered a partnership to establish a company based in the United Arab Emirates and introduce Actiste...
Brighter's Annual General Shareholders Meeting was held on Wednesday May 16, 2018 at the company's address in Stockholm, Kista.
The annual gene...
The full Interim report is available on Brighter's website www.brighter.se. The Interim report is also attached as a pdf file to this press releas...
Brighter has called upon a sixth Tranche of SEK 10 million in line with the terms from the financing agreement communicated on the 26thof April 20...
The second exercise period for Brighter's warrants of series TO3 is now completed. The company thereby strengthens its financing with 884 444 SEK,...
At Brighter's upcoming annual general shareholders meeting, the Company's Nomination Committee will propose changes to the Board of Directors, wit...
Brighter AB (publ) will hold its Annual General Meeting (AGM) on Wednesday 16th of May 2018, at 11:00, at the offices of Brighter AB, Norgegatan 2...
At Brighter's upcoming shareholders meeting, the Board of Directors Nomination Committee will propose changes to the Board of Directors, with Barb...
Brighter's unique diabetes solution Actiste, introduced to the market in December 2017, has been awarded the prestigious Red Dot Award, in the Pro...
The first exercise period for Brighter's warrants of series TO4 is now completed. The company thereby strengthens its financing with 672 TSEK, rep...
Brighter's solution Actiste® have been nominated to Design-S Swedish Design Awards 2018, in the category Industrial and Product Design B2B. Design...
Brighter and FRISQ have initiated a strategic partnership to strengthen the infrastructure and increase the information flow in the healthcare sec...
From development to commercialization.
The full Year End Report is available on Brighter's website www.brighter.se. A pdf copy is also attached...
During the past year, Brighter has been working on finalizing and CE certifying the company's diabetes solution Actiste (http://actiste.com/). Due...
Petra Kaur Ljungman, who has been a member of Brighter's Board since 2014, is now formally appointed as Vice President of Marketing & Communicatio...
Brighter participates in the Swedish delegation of approximately 160 companies at Mobile World Congress (MWC) in Barcelona. The fair is the world'...
As part of our financing strategy and the agreement with L1 Capital, Brighter has distributed free warrants to the company's shareholders to reduc...
The publication of Brighter's year-end report 2017 is moved from February 23 to March 23 due to implementation of a new accounting principle (IFRS...
The European Patent Office has granted Brighter's patent application no. 14864054.3, regarding method and device for logging drug injections made ...
Conversion of convertible notes into shares under the Convertible Notes issued under the financing agreement announced on April 26.
Change in...